Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
Sirona BiochemCorporate Update For April 2024
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
Sirona BiochemCorporate Update For April 2024
Apr 8, 2024 3:26 AM
06:04 AM EDT, 04/08/2024 (MT Newswires) -- Sirona Biochem Corp. ( SRBCF ) earlier Monday
Previous page:
Probe Gold Highlights Final Set of Results From 2023 Courvan Gold Trend Drill Program on Novador Property
Next page:
Pembina gets Canadian regulatory approval to buy Enbridge's interest in JVs
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Probe Gold Highlights Final Set of Results From 2023 Courvan Gold Trend Drill Program on Novador Property
Mar 19, 2024
07:22 AM EDT, 03/19/2024 (MT Newswires) -- Probe Gold Inc. ( PROBF ) , which rose 3.3% yesterday, on Tuesday highlighted the final set of results from the 2023 Courvan Gold Trend drill program on its Novador property located near Val-d'Or, Quebec. Results from 47 drill holes, totaling 12,200 meters, have returned significant gold intercepts from surface to 150 meters...
Pembina gets Canadian regulatory approval to buy Enbridge's interest in JVs
Mar 19, 2024
March 19 (Reuters) - Pembina Pipeline ( PBA ) said on Tuesday the Canadian Competition Bureau has approved its proposed C$3.1 billion ($2.28 billion) acquisition of Enbridge's ( ENB ) interests in the Alliance, Aux Sable, and NRGreen joint ventures. The deal is expected to close on April 1, Pembina said. Alliance delivers liquids-rich natural gas sourced in Northeast B.C.,...
Caleres' Fiscal Q4 Adjusted Earnings, Net Sales Increase; Sets Fiscal Q1, Fiscal 2024 Outlook -- Shares Drop Premarket
Mar 19, 2024
07:24 AM EDT, 03/19/2024 (MT Newswires) -- Caleres ( CAL ) reported fiscal Q4 adjusted earnings Tuesday of $0.86 per diluted share, up from $0.65 a year earlier. Analysts polled by Capital IQ expected $0.85. Net sales for the quarter ended Feb. 3 were $697.1 million, up from $696.4 million a year earlier. Analysts surveyed by Capital IQ expected $694.3...
XORTX Therapeutics Provides Update
Mar 19, 2024
07:18 AM EDT, 03/19/2024 (MT Newswires) -- XORTX Therapeutics Inc. ( XRTX ) , a late-stage clinical pharmaceutical company developing therapies to treat progressive kidney disease, on Tuesday provided an overview of its 2023 achievements. The company said that In support of pharmaceutical partnership discussions, XORTX initiated an independent commercial assessment of the XRx-008 program for ADPKD with Bluestar BioAdvisors....
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP